Impel NeuroPharma goes public
Impel NeuroPharma, a Seattle-based pharmaceutical company, has raised $80 million after pricing its IPO of over 5.3 million shares at $15 per share.
Impel NeuroPharma, a Seattle-based pharmaceutical company, has raised $80 million after pricing its IPO of over 5.3 million shares at $15 per share.
Copyright PEI Media
Not for publication, email or dissemination